Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enzo Biochem (ENZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Enzo Biochem: Fiscal 1Q Earnings Snapshot

NEW YORK (AP) _ Enzo Biochem Inc. (ENZ) on Monday reported a loss of $6 million in its fiscal first quarter.

ENZ : 3.51 (-2.50%)
Enzo Biochem Reports Fiscal 2019 First Quarter Results

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics and therapeutics company, today reported operating results for the first fiscal quarter ended October 31, 2018, in addition to providing...

ENZ : 3.51 (-2.50%)
Enzo Biochem Schedules Teleconference to Discuss First Quarter 2019 Results Tuesday, December 11, 2018 at 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company, will hold a conference call to discuss fiscal 2019 first quarter results Tuesday, December 11, 2018,...

ENZ : 3.51 (-2.50%)
Enzo Biochem Reports Publication of Study on Therapeutic Candidate SK1-I Detailing Promising Results in a Model of Treatment-Resistant Breast Cancer

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics and therapeutics company, today reported the publication of a study in the Journal of Lipid Research by researchers at a collaborating...

ENZ : 3.51 (-2.50%)
Market Trends Toward New Normal in Polaris Industries, NIKE, Charles River Laboratories International, Actuant, Caesarstone, and Enzo Biochem -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Polaris Industries Inc....

ENZ : 3.51 (-2.50%)
PII : 86.78 (+1.59%)
ATU : 24.46 (+2.69%)
NKE : 85.38 (+0.83%)
CRL : 140.86 (+0.83%)
CSTE : 17.24 (+5.12%)
Enzo Biochem, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 16, 2018 / Enzo Biochem, Inc. (NYSE: ) will be discussing their earnings results in their 2018 FourthQuarter Earnings to be held on October16, 2018 at 8:30 AM Eastern...

ENZ : 3.51 (-2.50%)
Enzo Biochem: Fiscal 4Q Earnings Snapshot

NEW YORK (AP) _ Enzo Biochem Inc. (ENZ) on Monday reported a fiscal fourth-quarter loss of $5.8 million, after reporting a profit in the same period a year earlier.

ENZ : 3.51 (-2.50%)
Enzo Biochem Reports Fourth Quarter and Fiscal 2018 Results

Enzo Biochem Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company, today reported results for the fourth quarter and fiscal year ended July 31, 2018, in addition to announcing...

ENZ : 3.51 (-2.50%)
Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal 2018 Results Tuesday, October 16, 2018 at 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2018 fourth quarter and year end results Tuesday, October 16, 2018, at 8:30 AM E.T.

ENZ : 3.51 (-2.50%)
Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement Case

Enzo Biochem, Inc. (NYSE:ENZ) and its subsidiary Enzo Life Sciences, Inc. today announced that the Patent Trial and Appeal Board has denied a petition filed by Hologic, Inc. (NASDAQ:HOLX)...

ENZ : 3.51 (-2.50%)
HOLX : 46.29 (+2.34%)

Van Meerten Stock Picks

SecureWorks - Pick of the Day
My Stock Pick of the Day belongs to the security software company SecureWorks (SCWX).
SCWX -0.33
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar